HEADER HYDROLASE 27-FEB-03 1ONG TITLE SHV-1 BETA-LACTAMASE WITH A PENEM INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE SHV-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PIT-2; PENICILLINASE; COMPND 5 EC: 3.5.2.6; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 573; SOURCE 4 STRAIN: 15571; SOURCE 5 GENE: BLA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI STR. K-12 SUBSTR. DH10B; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 316385; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH10B; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBCSK; SOURCE 11 EXPRESSION_SYSTEM_GENE: BLA KEYWDS BETA-LACTAM HYDROLASE, PENICILLINASE, DETERGENT BINDING, DRUG DESIGN, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.NUKAGA,K.MAYAMA,R.A.BONOMO,J.R.KNOX REVDAT 5 30-OCT-24 1ONG 1 REMARK REVDAT 4 16-AUG-23 1ONG 1 REMARK REVDAT 3 24-JUL-19 1ONG 1 REMARK LINK REVDAT 2 24-FEB-09 1ONG 1 VERSN REVDAT 1 09-DEC-03 1ONG 0 JRNL AUTH M.NUKAGA,T.ABE,A.M.VENKATESAN,T.S.MANSOUR,R.A.BONOMO, JRNL AUTH 2 J.R.KNOX JRNL TITL INHIBITION OF CLASS A AND CLASS C BETA-LACTAMASES BY PENEMS: JRNL TITL 2 CRYSTALLOGRAPHIC STRUCTURES OF A NOVEL 1,4-THIAZEPINE JRNL TITL 3 INTERMEDIATE JRNL REF BIOCHEMISTRY V. 42 13152 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 14609325 JRNL DOI 10.1021/BI034986B REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.141 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.141 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.186 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3560 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 88320 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.135 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.135 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.179 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 3228 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 79815 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2008 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 296 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2344.9 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2002.7 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 47 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 22711 REMARK 3 NUMBER OF RESTRAINTS : 28932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 ANGLE DISTANCES (A) : 0.032 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.035 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.081 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.084 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.028 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.005 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.047 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.100 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ONG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAR-03. REMARK 100 THE DEPOSITION ID IS D_1000018470. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9349 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 87983 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 200 DATA REDUNDANCY : 11.60 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.37500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1SHV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG-6000, 50 MM HEPES, 0.56 MM REMARK 280 CYMAL-6, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.77750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.65750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.59150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.65750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.77750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.59150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 31 CD OE1 OE2 REMARK 470 LEU A 35 CD1 CD2 REMARK 470 GLN A 100 CD OE1 NE2 REMARK 470 LYS A 111 CE NZ REMARK 470 GLN A 197 CD OE1 NE2 REMARK 470 GLU A 240 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 55 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 55 NE - CZ - NH1 ANGL. DEV. = 6.5 DEGREES REMARK 500 ARG A 55 NE - CZ - NH2 ANGL. DEV. = -6.0 DEGREES REMARK 500 LEU A 57 O - C - N ANGL. DEV. = -10.0 DEGREES REMARK 500 ARG A 65 NE - CZ - NH1 ANGL. DEV. = -5.7 DEGREES REMARK 500 ARG A 65 NE - CZ - NH2 ANGL. DEV. = 7.0 DEGREES REMARK 500 ARG A 83 NE - CZ - NH1 ANGL. DEV. = 4.9 DEGREES REMARK 500 ARG A 83 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG A 83 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG A 161 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES REMARK 500 ASP A 176 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 ARG A 178 NE - CZ - NH1 ANGL. DEV. = -3.7 DEGREES REMARK 500 ARG A 215 CD - NE - CZ ANGL. DEV. = 15.8 DEGREES REMARK 500 ARG A 241 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG A 244 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ALA A 257 CB - CA - C ANGL. DEV. = 10.9 DEGREES REMARK 500 ARG A 292 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 57 -111.27 -92.21 REMARK 500 ALA A 59 106.60 -160.50 REMARK 500 MET A 69 -141.69 49.12 REMARK 500 TYR A 105 88.58 66.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MA4 A 310 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MA4 A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WY4 A 400 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SHV RELATED DB: PDB REMARK 900 STRUCTURE OF SHV-1 BETA-LACTAMASE(UNLIGANDED) REMARK 900 RELATED ID: 1G56 RELATED DB: PDB REMARK 900 STRUCTURE OF SHV-1 BETA-LACTAMASE INHIBITED BY TAZOBACTAM REMARK 900 RELATED ID: 1ONH RELATED DB: PDB REMARK 900 GC1 BETA-LACTAMASE WITH A PENEM INHIBITOR DBREF 1ONG A 26 292 UNP P14557 BLA1_ECOLI 22 286 SEQRES 1 A 265 SER PRO GLN PRO LEU GLU GLN ILE LYS LEU SER GLU SER SEQRES 2 A 265 GLN LEU SER GLY ARG VAL GLY MET ILE GLU MET ASP LEU SEQRES 3 A 265 ALA SER GLY ARG THR LEU THR ALA TRP ARG ALA ASP GLU SEQRES 4 A 265 ARG PHE PRO MET MET SER THR PHE LYS VAL VAL LEU CYS SEQRES 5 A 265 GLY ALA VAL LEU ALA ARG VAL ASP ALA GLY ASP GLU GLN SEQRES 6 A 265 LEU GLU ARG LYS ILE HIS TYR ARG GLN GLN ASP LEU VAL SEQRES 7 A 265 ASP TYR SER PRO VAL SER GLU LYS HIS LEU ALA ASP GLY SEQRES 8 A 265 MET THR VAL GLY GLU LEU CYS ALA ALA ALA ILE THR MET SEQRES 9 A 265 SER ASP ASN SER ALA ALA ASN LEU LEU LEU ALA THR VAL SEQRES 10 A 265 GLY GLY PRO ALA GLY LEU THR ALA PHE LEU ARG GLN ILE SEQRES 11 A 265 GLY ASP ASN VAL THR ARG LEU ASP ARG TRP GLU THR GLU SEQRES 12 A 265 LEU ASN GLU ALA LEU PRO GLY ASP ALA ARG ASP THR THR SEQRES 13 A 265 THR PRO ALA SER MET ALA ALA THR LEU ARG LYS LEU LEU SEQRES 14 A 265 THR SER GLN ARG LEU SER ALA ARG SER GLN ARG GLN LEU SEQRES 15 A 265 LEU GLN TRP MET VAL ASP ASP ARG VAL ALA GLY PRO LEU SEQRES 16 A 265 ILE ARG SER VAL LEU PRO ALA GLY TRP PHE ILE ALA ASP SEQRES 17 A 265 LYS THR GLY ALA GLY GLU ARG GLY ALA ARG GLY ILE VAL SEQRES 18 A 265 ALA LEU LEU GLY PRO ASN ASN LYS ALA GLU ARG ILE VAL SEQRES 19 A 265 VAL ILE TYR LEU ARG ASP THR PRO ALA SER MET ALA GLU SEQRES 20 A 265 ARG ASN GLN GLN ILE ALA GLY ILE GLY ALA ALA LEU ILE SEQRES 21 A 265 GLU HIS TRP GLN ARG HET MA4 A 300 46 HET MA4 A 310 10 HET WY4 A 400 21 HETNAM MA4 CYCLOHEXYL-HEXYL-BETA-D-MALTOSIDE HETNAM WY4 7-(5,6-DIHYDRO-8H-IMIDAZO[2,1-C][1,4]OXAZIN-2-YL)-6- HETNAM 2 WY4 FORMYL-2,7-DIHYDRO- [1,4]THIAZEPINE-3-CARBOXYLIC ACID FORMUL 2 MA4 2(C24 H44 O11) FORMUL 4 WY4 C13 H13 N3 O4 S FORMUL 5 HOH *296(H2 O) HELIX 1 1 GLN A 28 SER A 41 1 14 HELIX 2 2 THR A 71 ALA A 86 1 16 HELIX 3 3 ARG A 98 LEU A 102 5 5 HELIX 4 4 VAL A 108 LEU A 113 5 6 HELIX 5 5 VAL A 119 SER A 130 1 12 HELIX 6 6 ASP A 131 VAL A 142 1 12 HELIX 7 7 GLY A 143 ILE A 155 1 13 HELIX 8 8 THR A 167 GLU A 171 5 5 HELIX 9 9 THR A 182 SER A 196 1 15 HELIX 10 10 SER A 200 ASP A 213 1 14 HELIX 11 11 ALA A 217 LEU A 225 1 9 HELIX 12 12 GLU A 240 GLY A 242 5 3 HELIX 13 13 SER A 271 HIS A 289 1 19 SHEET 1 A 5 THR A 56 TRP A 60 0 SHEET 2 A 5 ARG A 43 ASP A 50 -1 N GLU A 48 O LEU A 57 SHEET 3 A 5 ARG A 259 ARG A 266 -1 O ILE A 260 N MET A 49 SHEET 4 A 5 ARG A 244 GLY A 251 -1 N ARG A 244 O LEU A 265 SHEET 5 A 5 PHE A 230 ALA A 237 -1 N PHE A 230 O GLY A 251 SHEET 1 B 2 PHE A 66 PRO A 67 0 SHEET 2 B 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 C 2 LYS A 94 ILE A 95 0 SHEET 2 C 2 MET A 117 THR A 118 -1 O MET A 117 N ILE A 95 SSBOND 1 CYS A 77 CYS A 123 1555 1555 2.06 LINK OG SER A 70 C7 WY4 A 400 1555 1555 1.36 CISPEP 1 GLU A 166 THR A 167 0 2.90 SITE 1 AC1 24 ARG A 93 ILE A 95 HIS A 96 ARG A 98 SITE 2 AC1 24 VAL A 224 LEU A 225 PRO A 226 ALA A 248 SITE 3 AC1 24 VAL A 261 ILE A 263 ILE A 279 ALA A 280 SITE 4 AC1 24 GLY A 283 ALA A 284 GLU A 288 HOH A 517 SITE 5 AC1 24 HOH A 564 HOH A 586 HOH A 619 HOH A 630 SITE 6 AC1 24 HOH A 638 HOH A 675 HOH A 687 HOH A 798 SITE 1 AC2 12 MET A 69 SER A 70 TYR A 105 SER A 130 SITE 2 AC2 12 ASN A 132 GLU A 166 ASN A 170 GLY A 236 SITE 3 AC2 12 ALA A 237 HOH A 501 HOH A 627 HOH A 760 CRYST1 49.555 55.183 85.315 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020180 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018122 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011721 0.00000